172 related articles for article (PubMed ID: 10809017)
1. Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy.
Kimberlin DW; Malis DJ
Antiviral Res; 2000 Feb; 45(2):83-93. PubMed ID: 10809017
[TBL] [Abstract][Full Text] [Related]
2. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
Kimberlin DW
Antiviral Res; 2004 Sep; 63(3):141-51. PubMed ID: 15451182
[TBL] [Abstract][Full Text] [Related]
3. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
4. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
[TBL] [Abstract][Full Text] [Related]
5. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of recurrent respiratory papillomatosis.
Kimberlin DW
Expert Opin Pharmacother; 2002 Aug; 3(8):1091-9. PubMed ID: 12150688
[TBL] [Abstract][Full Text] [Related]
9. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
Go C; Schwartz MR; Donovan DT
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
[TBL] [Abstract][Full Text] [Related]
10. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
12. Recurrent respiratory papillomatosis.
Venkatesan NN; Pine HS; Underbrink MP
Otolaryngol Clin North Am; 2012 Jun; 45(3):671-94, viii-ix. PubMed ID: 22588043
[TBL] [Abstract][Full Text] [Related]
13. Recurrent respiratory papillomatosis: A state-of-the-art review.
Fortes HR; von Ranke FM; Escuissato DL; Araujo Neto CA; Zanetti G; Hochhegger B; Souza CA; Marchiori E
Respir Med; 2017 May; 126():116-121. PubMed ID: 28427542
[TBL] [Abstract][Full Text] [Related]
14. Factors Related to Extralaryngeal Spread in Juvenile Recurrent Respiratory Papillomatosis.
Labedz G; Scatolini ML; Ruvinsky S; Rodriguez HA
Laryngoscope; 2021 Jul; 131(7):1652-1656. PubMed ID: 33274778
[TBL] [Abstract][Full Text] [Related]
15. Vocal cord surgery and pharmacological treatment of a patient with HPV and recurrent respiratory papillomatosis.
Galletti F; Freni F; Gazia F; Gallo A
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31732543
[TBL] [Abstract][Full Text] [Related]
16. [Perspectives on recurrent respiratory papillomatosis and human papillomavirus].
Trolle S; Lynggaard CD; Gregersen KG; Baandrup L; Grønhøj C; Buchwald CV
Ugeskr Laeger; 2019 Oct; 181(41):. PubMed ID: 31610833
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus (HPV) Genotype Distribution in Patients with Recurrent Respiratory Papillomatosis (RRP) in Iran.
Eftekhaar NS; Karbalaie Niya MH; Izadi F; Teaghinezhad-S S; Keyvani H
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1973-1976. PubMed ID: 28749631
[TBL] [Abstract][Full Text] [Related]
18. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP).
Bonnez W; Kashima HK; Leventhal B; Mounts P; Rose RC; Reichman RC; Shah KV
Virology; 1992 May; 188(1):384-7. PubMed ID: 1314464
[TBL] [Abstract][Full Text] [Related]
20. Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation.
Mitsumoto GL; Bernardi FDC; Paes JF; Villa LL; Mello B; Pozzan G
Autops Case Rep; 2018; 8(3):e2018035. PubMed ID: 30101139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
